1. Home
  2. TEVA
  3. TEVA News

Latest Teva Pharmaceutical Industries Limited (TEVA) News on November 21, 2024

Teva Pharmaceutical (TEVA): The Global Leader in Affordable Medicine Under $25
TEVA

Insider Monkey

9 hours ago

Teva Pharmaceutical (TEVA): The Global Leader in Affordable Medicine Under $25

TEVA

Argus Research

3 days ago

Weekly Stock List

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
TEVA

Insider Monkey

6 days ago

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory

TEVA

Argus Research

7 days ago

Analyst Report: Teva Phar Inds Lt

TEVA

Argus Research

7 days ago

Market Update: CP, TEVA, MET, IGT

Teva to Present at the Jefferies London Healthcare Conference
TEVA

GlobeNewswire

13 days ago

Teva to Present at the Jefferies London Healthcare Conference

Are Investors Undervaluing Teva Pharmaceutical Industries (TEVA) Right Now?
TEVA

Zacks

13 days ago

Are Investors Undervaluing Teva Pharmaceutical Industries (TEVA) Right Now?

Amicus' Q3 Earnings & Revenues Beat Estimates, '24 View Updated
TEVA

Zacks

14 days ago

Amicus' Q3 Earnings & Revenues Beat Estimates, '24 View Updated

TEVA Stock Down 7% Despite Q3 Earnings & Sales Beat, Guidance Increase
TEVA

Zacks

14 days ago

TEVA Stock Down 7% Despite Q3 Earnings & Sales Beat, Guidance Increase

Teva Pharmaceutical Industries Ltd (TEVA) Q3 2024 Earnings Call Highlights: Strong Revenue ...
TEVA

GuruFocus.com

14 days ago

Teva Pharmaceutical Industries Ltd (TEVA) Q3 2024 Earnings Call Highlights: Strong Revenue ...

'This Is A New Teva,' Says CEO. But Investors Don't Seem To Believe.
TEVA

Investor's Business Daily

15 days ago

'This Is A New Teva,' Says CEO. But Investors Don't Seem To Believe.

TEVA

Morningstar Research

15 days ago

Analyst Report: Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries (TEVA) Q3 2024 Earnings Call Transcript
TEVA

Motley Fool

15 days ago

Teva Pharmaceutical Industries (TEVA) Q3 2024 Earnings Call Transcript

Teva's Explosive Q3 Results: Pivot to Growth Strategy Shocks Investors with Record Revenue Surge
TEVA

GuruFocus.com

15 days ago

Teva's Explosive Q3 Results: Pivot to Growth Strategy Shocks Investors with Record Revenue Surge

Teva Pharmaceutical Industries (TEVA) Reports Q3 Earnings: What Key Metrics Have to Say
TEVA

Zacks

15 days ago

Teva Pharmaceutical Industries (TEVA) Reports Q3 Earnings: What Key Metrics Have to Say

Teva Pharmaceutical Flashes A Buy Signal On Upbeat Third-Quarter Report
TEVA

Investor's Business Daily

15 days ago

Teva Pharmaceutical Flashes A Buy Signal On Upbeat Third-Quarter Report

TEVA

MT Newswires

15 days ago

Teva Pharmaceutical Q3 Non-GAAP Earnings, Net Revenue Rise; 2024 Outlook Updated

Teva Announces Strong Financial Results for the Third Quarter of 2024, led by Generics Performance and Innovative Portfolio Growth; Raises 2024 Financial Outlook including on Revenues, Adjusted EBITDA and Non-GAAP EPS
TEVA

GlobeNewswire

15 days ago

Teva Announces Strong Financial Results for the Third Quarter of 2024, led by Generics Performance and Innovative Portfolio Growth; Raises 2024 Financial Outlook including on Revenues, Adjusted EBITDA and Non-GAAP EPS

What's in Store for These 5 Drug & Biotech Stocks in Q3 Earnings?
TEVA

Zacks

16 days ago

What's in Store for These 5 Drug & Biotech Stocks in Q3 Earnings?

Teva Pharmaceutical Industries (TEVA) Upgraded to Strong Buy: What Does It Mean for the Stock?
TEVA

Zacks

17 days ago

Teva Pharmaceutical Industries (TEVA) Upgraded to Strong Buy: What Does It Mean for the Stock?

TEVA

MT Newswires

20 days ago

Teva Pharmaceuticals Schizophrenia Drug Delivery Trial Shows Improvement in Social Functioning

Teva Presents New Tardive Dyskinesia Data at Psych Congress 2024 from the IMPACT-TD Registry, Revealing Differences in Patient Experience Based on Underlying Psychiatric Condition
TEVA

GlobeNewswire

20 days ago

Teva Presents New Tardive Dyskinesia Data at Psych Congress 2024 from the IMPACT-TD Registry, Revealing Differences in Patient Experience Based on Underlying Psychiatric Condition

Teva Presents Latest Schizophrenia Treatment Research, Including Phase 3 SOLARIS Trial Results Demonstrating Improvements in Social Functioning and Quality of Life in Adults Receiving TEV-'749 (olanzapine) a Subcutaneous Long-Acting Injectable as well as Results of Real-World Analyses of UZEDY® (risperidone)
TEVA

GlobeNewswire

20 days ago

Teva Presents Latest Schizophrenia Treatment Research, Including Phase 3 SOLARIS Trial Results Demonstrating Improvements in Social Functioning and Quality of Life in Adults Receiving TEV-'749 (olanzapine) a Subcutaneous Long-Acting Injectable as well as Results of Real-World Analyses of UZEDY® (risperidone)

Countdown to Teva Pharmaceutical Industries (TEVA) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
TEVA

Zacks

20 days ago

Countdown to Teva Pharmaceutical Industries (TEVA) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS

EC fines Teva $502m over multiple sclerosis treatment Copaxone practices
TEVA

Pharmaceutical Technology

20 days ago

EC fines Teva $502m over multiple sclerosis treatment Copaxone practices

TEVA

Morningstar Research

21 days ago

Analyst Report: Teva Pharmaceutical Industries Limited

EU Commission fines Teva $500 million for trying to stop rival's multiple sclerosis drug
TEVA

Associated Press Finance

21 days ago

EU Commission fines Teva $500 million for trying to stop rival's multiple sclerosis drug

TEVA

MT Newswires

21 days ago

Update: European Commission Fines Teva $502.8 Million

TEVA

MT Newswires

21 days ago

European Commission Fines Teva $502.8 Million

Teva Fined Around $500 Million by EU Over MS Drug Competition Concerns
TEVA

The Wall Street Journal

21 days ago

Teva Fined Around $500 Million by EU Over MS Drug Competition Concerns

Teva Statement on European Commission Decision; Company to Appeal
TEVA

GlobeNewswire

21 days ago

Teva Statement on European Commission Decision; Company to Appeal

Investors in Teva Pharmaceutical Industries (NYSE:TEVA) have seen impressive returns of 120% over the past year
TEVA

Simply Wall St.

a month ago

Investors in Teva Pharmaceutical Industries (NYSE:TEVA) have seen impressive returns of 120% over the past year

Wall Street Analysts Predict a 25.1% Upside in Teva Pharmaceutical Industries (TEVA): Here's What You Should Know
TEVA

Zacks

a month ago

Wall Street Analysts Predict a 25.1% Upside in Teva Pharmaceutical Industries (TEVA): Here's What You Should Know

Biotech Stock Roundup: FOLD Settles Patent Dispute, Updates From EDIT & More
TEVA

Zacks

a month ago

Biotech Stock Roundup: FOLD Settles Patent Dispute, Updates From EDIT & More

Should Value Investors Buy Teva Pharmaceutical Industries (TEVA) Stock?
TEVA

Zacks

a month ago

Should Value Investors Buy Teva Pharmaceutical Industries (TEVA) Stock?

Are Medical Stocks Lagging Teva Pharmaceutical Industries (TEVA) This Year?
TEVA

Zacks

a month ago

Are Medical Stocks Lagging Teva Pharmaceutical Industries (TEVA) This Year?

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
TEVA

Insider Monkey

a month ago

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory

TEVA

MT Newswires

a month ago

Alvotech, Teva's Stelara Biosimilar Gets FDA Approval for New IV Presentation

Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI™ (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara® (ustekinumab)
TEVA

GlobeNewswire

a month ago

Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI™ (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara® (ustekinumab)

FOLD Stock Rises on Settling Galafold Patent Dispute With Teva
TEVA

Zacks

a month ago

FOLD Stock Rises on Settling Galafold Patent Dispute With Teva

Amicus Therapeutics (FOLD) Stock Jumps 14.0%: Will It Continue to Soar?
TEVA

Zacks

a month ago

Amicus Therapeutics (FOLD) Stock Jumps 14.0%: Will It Continue to Soar?

TEVA

MT Newswires

a month ago

Update: Amicus Therapeutics Shares Surge After Settling Patent Suit Against Teva Pharmaceuticals With License Deal

Amicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug
TEVA

Benzinga

a month ago

Amicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug

TEVA

MT Newswires

a month ago

Amicus Therapeutics Settles Patent Suit Against Teva Pharmaceuticals with License Agreement

TEVA

MT Newswires

a month ago

Sector Update: Health Care Stocks Higher Friday Afternoon

TEVA

MT Newswires

a month ago

Sector Update: Health Care

Teva Pays $450M To Resolve Alleged Kickback, Price-Fixing Schemes
TEVA

Benzinga

a month ago

Teva Pays $450M To Resolve Alleged Kickback, Price-Fixing Schemes

TEVA

MT Newswires

a month ago

Update: Teva Pharmaceutical to Pay $450 Million to Settle Anti-Kickback Allegations

TEVA

MT Newswires

a month ago

Teva Pharmaceutical to Pay $450 Million to Settle Anti-Kickback Allegations

Teva Pharmaceuticals to Pay $450 Million to Settle Kickback Allegations
TEVA

The Wall Street Journal

a month ago

Teva Pharmaceuticals to Pay $450 Million to Settle Kickback Allegations

Teva Pharmaceutical Industries Ltd (TEVA) Q2 2024 Earnings Call Highlights: Strong Revenue ...
TEVA

GuruFocus.com

a month ago

Teva Pharmaceutical Industries Ltd (TEVA) Q2 2024 Earnings Call Highlights: Strong Revenue ...

TEVA

MT Newswires

a month ago

Teva Pharmaceutical Says it Receives FDA, EMA Acceptance for Prolia Biosimilar Candidate Applications

Teva Prolia® (Denosumab) Biosimilar Candidate is Accepted for Review by U.S. FDA and EU EMA
TEVA

GlobeNewswire

a month ago

Teva Prolia® (Denosumab) Biosimilar Candidate is Accepted for Review by U.S. FDA and EU EMA

Are Investors Undervaluing Teva Pharmaceutical Industries (TEVA) Right Now?
TEVA

Zacks

a month ago

Are Investors Undervaluing Teva Pharmaceutical Industries (TEVA) Right Now?

Is Teva Pharmaceutical Industries (TEVA) Stock Outpacing Its Medical Peers This Year?
TEVA

Zacks

a month ago

Is Teva Pharmaceutical Industries (TEVA) Stock Outpacing Its Medical Peers This Year?

Teva and mAbxience partner to develop biosimilar candidate for oncology
TEVA

Pharmaceutical Technology

2 months ago

Teva and mAbxience partner to develop biosimilar candidate for oncology

TEVA

MT Newswires

2 months ago

Teva Unit, mAbxience Partner to Develop Anti-PD-1 Oncology Biosimilar

Teva and mAbxience Expand Strategic Partnership to include an additional Oncology Biosimilar Candidate
TEVA

GlobeNewswire

2 months ago

Teva and mAbxience Expand Strategic Partnership to include an additional Oncology Biosimilar Candidate

TEVA

MT Newswires

2 months ago

Teva Pharmaceutical's US Affiliate Launches Octreotide Acetate for Injectable Suspension

Teva Announces Launch of the First and Only Generic Version of Sandostatin® LAR Depot (octreotide acetate for injectable suspension), in the U.S.
TEVA

GlobeNewswire

2 months ago

Teva Announces Launch of the First and Only Generic Version of Sandostatin® LAR Depot (octreotide acetate for injectable suspension), in the U.S.

Why Are Analysts Bullish On Teva Pharmaceutical Industries Limited (TEVA) Right Now?
TEVA

Insider Monkey

2 months ago

Why Are Analysts Bullish On Teva Pharmaceutical Industries Limited (TEVA) Right Now?

Teva to Host Conference Call to Discuss Third Quarter 2024 Financial Results at 8 a.m. ET on November 6, 2024
TEVA

GlobeNewswire

2 months ago

Teva to Host Conference Call to Discuss Third Quarter 2024 Financial Results at 8 a.m. ET on November 6, 2024

Invesco EQV European Equity Fund Bolsters Position in Teva Pharmaceutical with a 1. ...
TEVA

GuruFocus.com

2 months ago

Invesco EQV European Equity Fund Bolsters Position in Teva Pharmaceutical with a 1. ...

Teva touts safety profile of once monthly schizophrenia therapy
TEVA

Pharmaceutical Technology

2 months ago

Teva touts safety profile of once monthly schizophrenia therapy

Teva touts safety profile of once-monthly schizophrenia therapy
TEVA

Clinical Trials Arena

2 months ago

Teva touts safety profile of once-monthly schizophrenia therapy

TEVA

MT Newswires

2 months ago

Teva Pharmaceutical's Movement Disorder Drug Shows Sustained Improvement in Extension Study

Teva Announces Long Term Efficacy and Safety of Deutetrabenazine in European Patients with Debilitating Movement Disorder Tardive Dyskinesia
TEVA

GlobeNewswire

2 months ago

Teva Announces Long Term Efficacy and Safety of Deutetrabenazine in European Patients with Debilitating Movement Disorder Tardive Dyskinesia

Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable for Adult Patients Diagnosed with Schizophrenia
TEVA

GlobeNewswire

2 months ago

Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable for Adult Patients Diagnosed with Schizophrenia

New Data Provide Treatment Insights into Options for Switching Adult Patients Diagnosed with Schizophrenia to UZEDY® (risperidone) Extended-Release Injectable Suspension from Perseris® (RBP-7000)
TEVA

GlobeNewswire

2 months ago

New Data Provide Treatment Insights into Options for Switching Adult Patients Diagnosed with Schizophrenia to UZEDY® (risperidone) Extended-Release Injectable Suspension from Perseris® (RBP-7000)

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is favoured by institutional owners who hold 68% of the company
TEVA

Simply Wall St.

2 months ago

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is favoured by institutional owners who hold 68% of the company

TEVA Stock Rises 72.5% This Year: Time to Buy, Sell or Hold?
TEVA

Zacks

2 months ago

TEVA Stock Rises 72.5% This Year: Time to Buy, Sell or Hold?

Teva to Present at the Bank of America 2024 Global Healthcare Conference
TEVA

GlobeNewswire

2 months ago

Teva to Present at the Bank of America 2024 Global Healthcare Conference

Baltimore settles with Teva, Walgreens ahead of scheduled opioid trial
TEVA

Reuters

2 months ago

Baltimore settles with Teva, Walgreens ahead of scheduled opioid trial

TEVA

MT Newswires

2 months ago

Sector Update: Health Care Stocks Advance Late Afternoon

Teva agrees to pay Baltimore City $80m for fuelling opioid epidemic
TEVA

Pharmaceutical Technology

2 months ago

Teva agrees to pay Baltimore City $80m for fuelling opioid epidemic

TEVA

MT Newswires

2 months ago

Sector Update: Health Care Stocks Rise in Afternoon Trading

TEVA

MT Newswires

2 months ago

Update: Teva Pharmaceutical Faces Fine in EU for Dismissive Tactics Against Rivals

TEVA

MT Newswires

2 months ago

Teva Pharmaceutical Faces Fine in EU for Dismissive Tactics Against Rivals

JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability
TEVA

Benzinga

2 months ago

JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability

TEVA

MT Newswires

3 months ago

CareRx Appoints Suzanne Brand as Chief Financial Officer

TEVA

MT Newswires

3 months ago

UBS Raises Price Target on Teva Pharmaceutical Industries to $26 From $24, Maintains Buy Rating

TEVA

Morningstar Research

3 months ago

Analyst Report: Teva Pharmaceutical Industries Limited

Teva to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
TEVA

GlobeNewswire

3 months ago

Teva to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

TEVA

MT Newswires

3 months ago

BofA Securities Raises Price Target on Teva Pharmaceutical Industries to $22 From $21, Maintains Buy Rating

TEVA

Argus Research

3 months ago

Weekly Stock List

TEVA

Argus Research

3 months ago

Daily Spotlight: More Progress on Inflation

TEVA

MT Newswires

3 months ago

Teva Pharmaceutical Industries Insider Sold Shares Worth $782,972, According to a Recent SEC Filing

TEVA

Argus Research

3 months ago

Weekly Stock List

TEVA

Argus Research

3 months ago

Summer Shakeout as the Market Waits for the Fed

Teva Pharmaceutical Industries Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
TEVA

Simply Wall St.

4 months ago

Teva Pharmaceutical Industries Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

TEVA

Argus Research

4 months ago

Analyst Report: Teva Phar Inds Lt

TEVA

Argus Research

4 months ago

Market Digest: TEVA, HIG, LRCX, MAS, MRK, SBUX, WDC, META, HCA, IGT, RITM

TEVA Q2 Earnings Beat, Generic Business Drives Sales, Stock Up
TEVA

Zacks

4 months ago

TEVA Q2 Earnings Beat, Generic Business Drives Sales, Stock Up

Teva Pharma, With A 67% Gain This Year, Flirts With A Breakout On Beat-And-Raise Report
TEVA

Investor's Business Daily

4 months ago

Teva Pharma, With A 67% Gain This Year, Flirts With A Breakout On Beat-And-Raise Report

TEVA

Morningstar Research

4 months ago

Analyst Report: Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries (TEVA) Q2 2024 Earnings Call Transcript
TEVA

Motley Fool

4 months ago

Teva Pharmaceutical Industries (TEVA) Q2 2024 Earnings Call Transcript

Teva Pharmaceutical Industries (TEVA) Reports Q2 Earnings: What Key Metrics Have to Say
TEVA

Zacks

4 months ago

Teva Pharmaceutical Industries (TEVA) Reports Q2 Earnings: What Key Metrics Have to Say

Teva Pharma Flirts With Breakout As Generic Drugs Drive Beat-And-Raise
TEVA

Investor's Business Daily

4 months ago

Teva Pharma Flirts With Breakout As Generic Drugs Drive Beat-And-Raise

Is Teva Pharmaceutical Industries (TEVA) Stock Undervalued Right Now?
TEVA

Zacks

4 months ago

Is Teva Pharmaceutical Industries (TEVA) Stock Undervalued Right Now?

TEVA

MT Newswires

4 months ago

Teva Pharmaceutical Q2 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Revised

Share on Social Networks: